We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+1.13%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$10.4B
AUM Growth
-$279M
(-2.6%)
Cap. Flow
-$218M
Cap. Flow
% of AUM
-2.1%
Top 10 Holdings %
Top 10 Hldgs %
17.29%
Holding
1,364
New
413
Increased
268
Reduced
302
Closed
358
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$105M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$103M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$97.6M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$77.4M |
| 5 |
Humana
HUM
|
+$71.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$125M |
| 2 |
Perrigo
PRGO
|
+$103M |
| 3 |
AGN
Allergan plc
AGN
|
+$99.6M |
| 4 |
Pfizer
PFE
|
+$90M |
| 5 |
Viatris
VTRS
|
+$88.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.63% |
| 2 | Healthcare | 15.57% |
| 3 | Communication Services | 13.26% |
| 4 | Technology | 11.56% |
| 5 | Financials | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TARO
751
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $829K | 0.01% |
5,787
-25,992
| -82% | -$3.69M |
|
752
American Homes 4 Rent
AMH
$12B
| $823K | 0.01% |
+51,763
| New | +$775K |
|
753
Jack in the Box
JACK
$278M
| $822K | 0.01% |
+12,865
| New | +$904K |
|
754
Northrop Grumman
NOC
$77B
| $822K | 0.01% |
4,150
-282,297
| -99% | -$53.3M |
|
|
MIC
755
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $812K | 0.01% |
12,042
-91,596
| -88% | -$5.81M |
|
|
SIVB
756
DELISTED
SVB Financial Group
SIVB
| $811K | 0.01% |
7,944
-301,046
| -97% | -$29.1M |
|
757
Walmart Inc
WMT
$871B
| $809K | 0.01% |
+35,418
| New | +$777K |
|
758
Infosys
INFY
$45B
| $806K | 0.01% |
+84,782
| New | +$739K |
|
759
Archer Daniels Midland
ADM
$41.4B
| $780K | 0.01% |
21,489
-19,115
| -47% | -$665K |
|
760
Air Products & Chemicals
APD
$66.3B
| $776K | 0.01% |
5,821
-2,213
| -28% | -$268K |
|
|
TEP
761
DELISTED
Tallgrass Energy Partners, LP
TEP
| $773K | 0.01% |
+20,167
| New | +$705K |
|
762
Conagra Brands
CAG
$7.07B
| $763K | 0.01% |
21,986
-6,502
| -23% | -$211K |
|
|
KND
763
DELISTED
Kindred Healthcare
KND
| $763K | 0.01% |
+61,791
| New | +$641K |
|
764
Carnival Corporation Ltd
CCL
$36.1B
| $757K | 0.01% |
14,350
-10,198
| -42% | -$493K |
|
|
HTS
765
DELISTED
HATTERAS FINANCIAL CORP
HTS
| $750K | 0.01% |
+52,458
| New | +$691K |
|
766
US Physical Therapy
USPH
$1.14B
| $749K | 0.01% |
+15,064
| New | +$749K |
|
|
CUK
767
DELISTED
Carnival PLC
CUK
| $748K | 0.01% |
+13,777
| New | +$693K |
|
|
DWA
768
DELISTED
DREAMWORKS ANIMATION SKG INC CL-A
DWA
| $742K | 0.01% |
29,727
-5,047
| -15% | -$124K |
|
|
AIRM
769
DELISTED
Air Methods Corp
AIRM
| $726K | 0.01% |
+20,051
| New | +$761K |
|
770
Materion
MTRN
$5.01B
| $719K | 0.01% |
+27,163
| New | +$677K |
|
|
FNSR
771
DELISTED
Finisar Corp
FNSR
| $716K | 0.01% |
39,274
-227
| -0.6% | -$3.27K |
|
772
Restaurant Brands International
QSR
$25.1B
| $715K | 0.01% |
18,418
-461,999
| -96% | -$16.1M |
|
773
AAR Corp
AIR
$5.15B
| $712K | 0.01% |
30,612
-54,368
| -64% | -$1.18M |
|
774
Louisiana-Pacific
LPX
$5.2B
| $711K | 0.01% |
+41,538
| New | +$657K |
|
775
KT
KT
$8.84B
| $706K | 0.01% |
+52,617
| New | +$634K |
|
Similar funds
Marshall Wace's Q1 2016 Portfolio in Review
As of Q1 2016, Marshall Wace held 1,364 positions worth $10.4B, down 2.6% from $10.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q1 2016 filing shows 413 new, 268 increased, 302 reduced and 358 closed positions. Its largest new stake was iShares MSCI Emerging Markets ETF: 3,149,620 shares worth $108M. The largest sale was Bristol-Myers Squibb, an estimated $125M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 12% a quarter earlier, followed by Healthcare and Communication Services.
- Marshall Wace's largest Q1 2016 buy was iShares MSCI Emerging Markets ETF: 3,149,620 shares worth $108M.
- Marshall Wace added most to Adobe in Q1 2016, an estimated $105M increase.
- Marshall Wace's biggest Q1 2016 reduction was Bristol-Myers Squibb, cutting an estimated $125M.
- Marshall Wace fully exited Perrigo in Q1 2016, selling an estimated $103M.
- Marshall Wace's ten largest holdings make up 17% of its $10.4B portfolio in Q1 2016.
- Marshall Wace opened 413 new positions and closed 358 in Q1 2016.
- Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $10.4B.
Based on Marshall Wace's 13F filing for Q1 2016, filed 13 May 2016.